Evidence map›Paper›PMID 30846310›Full record

ArticleNeuron2019

Axo-axonic Innervation of Neocortical Pyramidal Neurons by GABAergic Chandelier Cells Requires AnkyrinG-Associated L1CAM.

Yilin Tai, Nicholas B Gallo, Minghui Wang, Jia-Ray Yu, Linda Van Aelst

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Neuron, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Cortical control of chandelier cells in neural codes.Frontiers in cellular neuroscience · 2022
    Pooled it
  3. Article
  4. Review
  5. Article
  6. The Highly Localized Interaction between Neurofascin-186 and Gliomedin Promotes Subcellular Innervation by the Chandelier Cell.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  7. Hippocampal Chandelier Cells Modulate Seizure Susceptibility and Severity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Article
  9. Hide-and-Seek genome editing reveals that Gephyrin is required for axo-axonic synapse assembly.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yilin TaiCold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Nicholas B GalloCold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA; Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY 11794, USA.
Minghui WangCold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Jia-Ray YuCold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Linda Van AelstCold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA. Electronic address: vanaelst@cshl.edu.
Cold Spring Harbor Laboratory · USStony Brook University · US

Funding

Single-Cell Biology Shared ResourceP30CA045508 · NCI · COLD SPRING HARBOR LABORATORY · PI John Edward Moses · 1987 to 2026
$118.9M
DOCK7 Signaling in Neuronal DevelopmentR01MH082808 · NIMH · COLD SPRING HARBOR LABORATORY · PI VAN AELST, LINDA · 2008 to 2017
$4.7M
Molecular and cellular mechanisms governing interneuron development and connectivityR01MH119819 · NIMH · COLD SPRING HARBOR LABORATORY · PI VAN AELST, LINDA · 2019 to 2023
$3.3M
Neurodevelopmental Disorder-Associated Rho Regulators in Neocortical DevelopmentR01NS116897 · NINDS · COLD SPRING HARBOR LABORATORY · PI VAN AELST, LINDA · 2020 to 2024
$2.9M
Rho regulator-mediated signaling in interneuron developmentR01NS082266 · NINDS · COLD SPRING HARBOR LABORATORY · PI VAN AELST, LINDA · 2013 to 2017
$2.4M
Molecular mechanisms governing axo-axonic subcellular target recognition in the neocortexF31MH117871 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI GALLO, NICHOLAS BIRON · 2018 to 2020
$70k
NCI NIH HHS P30 CA045508NIMH NIH HHS F31 MH117871NIMH NIH HHS R01 MH082808NIMH NIH HHS R01 MH119819NINDS NIH HHS R01 NS082266NINDS NIH HHS R01 NS116897
6 · The paper itself

Abstract

Among the diverse interneuron subtypes in the neocortex, chandelier cells (ChCs) are the only population that selectively innervate pyramidal neurons (PyNs) at their axon initial segment (AIS), the site of action potential initiation, allowing them to exert powerful control over PyN output. Yet, mechanisms underlying their subcellular innervation of PyN AISs are unknown. To identify molecular determinants of ChC/PyN AIS innervation, we performed an in vivo RNAi screen of PyN-expressed axonal cell adhesion molecules (CAMs) and select Ephs/ephrins. Strikingly, we found the L1 family member L1CAM to be the only molecule required for ChC/PyN AIS innervation. Further, we show that L1CAM is required during both the establishment and maintenance of innervation, and that selective innervation of PyN AISs by ChCs requires AIS anchoring of L1CAM by the cytoskeletal ankyrin-G/βIV-spectrin complex. Thus, our findings identify PyN-expressed L1CAM as a critical CAM required for innervation of neocortical PyN AISs by ChCs. VIDEO ABSTRACT.

Indexed as

AnimalsAnkyrinsAxonsCell AdhesionCell Adhesion MoleculesEphrinsGABAergic NeuronsInterneuronsMiceNeocortexNerve Tissue ProteinsNeural Cell Adhesion Molecule L1Pyramidal CellsReceptor, EphA1SpectrinSynapsesAnk3 protein, mouseAnkyrinsbetaIV spectrinCell Adhesion MoleculesEphrinsNerve Tissue ProteinsNeural Cell Adhesion Molecule L1Receptor, EphA1Spectrin

Identifiers

PMID30846310
PMCPMC6525570
OpenAlexW2920792857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.